Drug Delivery Systems - EP4091652

The patent EP4091652 was granted to Pearl Therapeutics on Nov 29, 2023. The application was originally filed on Oct 5, 2018 under application number EP22170388A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4091652

PEARL THERAPEUTICS
Application Number
EP22170388A
Filing Date
Oct 5, 2018
Status
Granted And Under Opposition
Oct 27, 2023
Grant Date
Nov 29, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BECK GREENERAug 28, 2024BECK GREENERADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONUS2003051727
OPPOSITIONWO0230499
OPPOSITIONWO2007022573
OPPOSITIONWO2009029029
OPPOSITIONWO2011039196
OPPOSITIONWO9002576
SEARCHUS2007175537
SEARCHUS2009050149
SEARCHUS2009308772
SEARCHWO2008023015
SEARCHWO2010005946

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents